RE: Gilead & World Domination

[Guest guest]

" You're right in that Gilead has been an industry leader in coming up with

new meds, having a robust pipeline, and partnering with other companies to

market easy-to-take combos like Atripla. Being a pharmaceutical company,

they're not just doing it out of the goodness of their hearts--they're in it

to gain market share and make money. That said, I've worked with the company

over the years and the researchers that develop the new HIV treatments are a

dedicated bunch. "

No doubt that Gilead is a major innovator. Maybe they will relieve us from

the lock-in with regards to P450-CYP3A4-inhibition, where Abbott's Norvir

has the lead. I hope so.

But, as far as Europe is concerned, Gilead has delayed the availability of

Truvada for 2 years after obtaining their marketing licence from EMEA,

simply because of contract disagreements with their partner in Europe for

distribution, being UCB Pharma.

Only after hiv-advocacy groups took to Gilead for explanations, amongst ie

my letter to both boards when I was still active as a patient

representative, they settled.

That sadly changed my view of Gilead altogether as a partner.

,

Amsterdam, The Netherlands.